Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance - Test2 - elhamkhani - TriplyDB

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

http://www.wikidata.org/entity/Q28291556

about

Metabolic insight into mechanisms of high-altitude adaptation in Tibetans An overview of sphingolipid metabolism: from synthesis to breakdown A critical role for ceramide synthase 2 in liver homeostasis: II. insights into molecular changes leading to hepatopathy Central role of ceramide biosynthesis in body weight regulation, energy metabolism, and the metabolic syndrome Insulin resistance is a cellular antioxidant defense mechanism Lipid-Induced Insulin Resistance in Skeletal Muscle: The Chase for the Culprit Goes from Total Intramuscular Fat to Lipid Intermediates, and Finally to Species of Lipid Intermediates The Role of Organelle Stresses in Diabetes Mellitus and Obesity: Implication for Treatment Insulin receptor signaling in normal and insulin-resistant states Linking obesity with type 2 diabetes: the role of T-bet Dihydroceramides: From Bit Players to Lead Actors Sphingolipid signaling in metabolic disorders On ceramides, other sphingolipids and impaired glucose homeostasis The adipokine/ceramide axis: key aspects of insulin sensitization Effects of fatty acid treatments on the dexamethasone-induced intramuscular lipid accumulation in chickens Chronic Voluntary Ethanol Consumption Induces Favorable Ceramide Profiles in Selectively Bred Alcohol-Preferring (P) Rats Defect of insulin signal in peripheral tissues: Important role of ceramide Regulation of Nlrp3 inflammasome by dietary metabolites The cell biology of fat expansion Autophagy regulates sphingolipid levels in the liver Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease The effects of obesity on skeletal muscle regeneration Long-chain fatty acid combustion rate is associated with unique metabolite profiles in skeletal muscle mitochondria Increased hepatic insulin action in diet-induced obese mice following inhibition of glucosylceramide synthase Comparative plasma lipidome between human and cynomolgus monkey: are plasma polar lipids good biomarkers for diabetic monkeys?Identification of sphingolipid metabolites that induce obesity via misregulation of appetite, caloric intake and fat storage in Drosophila Fam57b (family with sequence similarity 57, member B), a novel peroxisome proliferator-activated receptor γ target gene that regulates adipogenesis through ceramide synthesis Ablation of dihydroceramide desaturase confers resistance to etoposide-induced apoptosis in vitro Palmitate-activated macrophages confer insulin resistance to muscle cells by a mechanism involving protein kinase C θ and ε Mechanisms for insulin resistance: common threads and missing links Sphingolipids and phospholipids in insulin resistance and related metabolic disorders.Role of ceramide in diabetes mellitus: evidence and mechanisms.Opening of the mitochondrial permeability transition pore links mitochondrial dysfunction to insulin resistance in skeletal muscle.Insulin resistance without elevated mammalian target of rapamycin complex 1 activity in muscles of mice fed a high-fat diet.Exercise dose response in muscle PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity.Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner.Reducing glycosphingolipid content in adipose tissue of obese mice restores insulin sensitivity, adipogenesis and reduces inflammation IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis Compensatory increases in nuclear PGC1alpha protein are primarily associated with subsarcolemmal mitochondrial adaptations in ZDF rats

P2860

Q24605065-61B56F9D-279D-4C99-9062-44C1DB87063F Q24628769-F331406C-DE31-406F-8F03-F375897199FB Q24634622-436EBFEC-1851-466B-AEED-B72ABADFB24C Q24648112-40B04CA9-8627-4136-896A-509D96355E13 Q24650976-01F28D16-9FB2-474E-8003-9C10B1E857D7 Q26739957-B5A3B18D-6621-48B4-A9B8-FE0ACB0776B9 Q26776377-19F6DF68-0E2A-4BA2-9CE6-D494C1705189 Q26823171-2E0BF359-F52C-4EF5-987C-541DDE095C4E Q26830915-B1418ABB-DACC-458E-8DAD-480F29E82EF0 Q26851948-F36FD14A-D47E-4780-A79B-B8FA92580408 Q26992148-AC8B11C2-7A75-4BE1-A10F-8FF66784AC4E Q27021446-4A08965B-9CD0-463D-9ACB-B8DEC296150B Q27025041-1262A62A-A086-43D7-83FD-BECA35A351A7 Q27303384-89D89CEB-4539-40ED-A355-89DF76DD912B Q27316398-29B25917-3B2D-44BE-9D40-10D264E04AC4 Q27690875-FCE8953F-E659-400B-8294-7F81E1494478 Q28078340-215BF959-03ED-47D8-AF89-DAB3B4FB77DA Q28084054-C5312910-A0A3-4516-9270-E24919C98530 Q28115515-6CC32F3B-B107-4C30-8D6F-141D0F7C4AF1 Q28253498-3CF2B37A-2E33-49A2-AA52-93C21491ACBC Q28259585-C0F01C79-F71B-4590-A930-A12BF22E0516 Q28393087-650FEA8B-70DD-4F53-9248-D0ECBB4CD374 Q28473405-293A7B5A-9F51-475E-9D61-691736C45EA1 Q28474576-AD17C08C-C805-4BC5-ACA4-58ED2DB4DA0E Q28478051-611894EA-1F6A-481B-9459-C6F8A4922BEC Q28536054-4A967FE6-5290-486B-9096-4C3998A18B15 Q28589295-336A3065-2321-4C24-9100-4469B0D5297C Q28595077-059B68C8-E698-4DF6-948E-9881CD710D77 Q28743444-613FDEE8-E29F-4D84-9EF3-9B0F807B818B Q29620447-CE5C9AD9-BDC2-4262-B97B-9394EB4BEC7B Q30241943-24006C58-50A5-4312-A7E2-AEA5859E13D2 Q30351934-FFF0CF3F-DC16-4B35-98FD-D67CDE312970 Q30414295-7A862506-3E2A-40B4-9D35-857772378D87 Q30417125-0A812650-E093-4643-9683-D4EA2ACEC510 Q30417219-C7C12A61-8700-403E-B591-D1F8AEC7EA35 Q30431199-6FA19D37-0B72-460A-A218-5F9EAD18675D Q30701525-9BB51939-2E1E-41FE-AEDA-1EB4C33A1E3E Q33420391-5B106A6F-C024-4A69-B5E7-D4113D3A513A Q33516564-86B1C48B-CE6C-40CB-8BFD-64010C5F2659 Q33526750-66424E9B-A472-422C-9A70-DBE59EEBEE20

P2860

Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance

http://www.wikidata.org/entity/Q28291556

description

2007 nî lūn-bûn

@nan

2007 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի մարտին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Inhibition of ceramide synthes ...... ity-induced insulin resistance

@ast

Inhibition of ceramide synthes ...... ity-induced insulin resistance

@en

Inhibition of ceramide synthes ...... ity-induced insulin resistance

@nl

type

label

Inhibition of ceramide synthes ...... ity-induced insulin resistance

@ast

Inhibition of ceramide synthes ...... ity-induced insulin resistance

@en

Inhibition of ceramide synthes ...... ity-induced insulin resistance

@nl

prefLabel

Inhibition of ceramide synthes ...... ity-induced insulin resistance

@ast

Inhibition of ceramide synthes ...... ity-induced insulin resistance

@en

Inhibition of ceramide synthes ...... ity-induced insulin resistance

@nl

P1433

Q28291556-90AA8809-2FA5-4F03-B1FC-DE0060B40B52

P1476

Q28291556-4E76ADDF-4259-4EF2-BCD3-A1A09CDF7A3A

P2093

Q28291556-076D2D4B-C4B6-47BC-98C8-06ACE6C1E829

Q28291556-21FA7C5C-60D2-4C6E-9433-2C54FF3F440C

Q28291556-2578F15D-2087-4242-AC51-2FA764A0161D

Q28291556-361EA02F-6574-48AE-9C25-A7A322CC6235

Q28291556-38B6F792-CC1D-4C17-BFC3-642683979FB5

Q28291556-61B91AE9-F82D-41BD-8B59-99B41C47EAD9

Q28291556-76397BA6-AB23-4B90-9978-C397875D9900

Q28291556-846461C0-536E-437D-9BF3-BBC2FB99D240

Q28291556-8EFF5F55-BFC4-4C1F-A7E3-235E94A8CE07

Q28291556-C71BC341-1F36-4159-B3EB-806FEBCF40C1

P304

Q28291556-11FF7017-906C-4CEA-96F0-FE6486331531

P31

Q28291556-7489AD12-9DBC-45AE-A3D1-A53C5BE20C2A

P3181

Q28291556-B8B3FDCA-78ED-4F53-ACC5-AA67F63589D8

P356

Q28291556-08D0843A-5735-45F1-891B-42085649A96D

P407

Q28291556-F272991E-48C6-493C-9513-08331FFEF21F

P433

Q28291556-51F4D352-B4D8-4AF3-ACFE-CC05D8A558EF

P478

Q28291556-874B0B5C-BB9E-451E-8AD3-BBCF534F5997

P50

Q28291556-74534758-F22E-421C-84F7-8D1B9F26CA38

Q28291556-B8D057B0-0D10-4CB2-B3DD-40BF68BC6F4D

P577

Q28291556-3697A220-D82C-4167-BEA9-1E6BD430B6AE

P5875

Q28291556-C8C845F2-C6D4-49DB-B471-3EDEA14BD5C6

P698

Q28291556-12AA51BB-70CB-43DE-AB2A-654B4C3A50F2

P921

Q28291556-27F55CED-5B9B-47CC-A179-2AEBC0F8F5BC

Q28291556-3B14C5EB-DA02-4ACE-AC5E-704824E390DB

Q28291556-A75E3D4D-6649-40EF-B585-BE2EF8128C5A

P3181

P356

J.CMET.2007.01.002

P1433

Cell Metabolism

P1476

Inhibition of ceramide synthes ...... ity-induced insulin resistance

@en

P2093

Angela Siesky

http://www.w3.org/2001/XMLSchema#string

Don H Nelson

http://www.w3.org/2001/XMLSchema#string

Eric D Hawkins

http://www.w3.org/2001/XMLSchema#string

Greg K Fontenot

http://www.w3.org/2001/XMLSchema#string

Joseph T Brozinick

http://www.w3.org/2001/XMLSchema#string

Katherine M Sargent

http://www.w3.org/2001/XMLSchema#string

Krishna Narra

http://www.w3.org/2001/XMLSchema#string

Li-Ping Wang

http://www.w3.org/2001/XMLSchema#string

Scott A Summers

http://www.w3.org/2001/XMLSchema#string

Sotirios K Karathanasis

http://www.w3.org/2001/XMLSchema#string

P304

167-79

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

161603

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CMET.2007.01.002

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Morris J. Birnbaum

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6467774

http://www.w3.org/2001/XMLSchema#string

P698

17339025

http://www.w3.org/2001/XMLSchema#string

P921